Illumina has been on fire lately. In the past six months alone, the company’s stock price has rocketed 47%, reaching $121.93 ...

Illumina, Inc. (NASDAQ:ILMN) reported better-than-expected earnings for the second quarter on Thursday. The company posted quarterly earnings of $1.19 per share which beat the analyst consensus ...

Illumina, Inc. ILMN recently announced the launch of Illumina Protein Prep, an assay designed to deliver superior performance for next-generation sequencing (NGS)-based proteomics discovery at scale.

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

Illumina, Inc. ILMN recently announced the launch of BioInsight, a new business unit developed to meet industry demand for deeper biologic insights, driven by the need of researchers and pharma ...